Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
7.32
+0.08 (1.10%)
At close: Feb 20, 2026, 4:00 PM EST
7.18
-0.14 (-1.91%)
After-hours: Feb 20, 2026, 7:08 PM EST
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $624.13 million as of February 20, 2026. Its market cap has increased by 168.17% in one year.
Market Cap
624.13M
Enterprise Value
565.42M
1-Year Change
168.17%
Ranking
Category
Stock Price
$7.32
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $624.13M, an increase of 79.77%. That is a compound annual growth rate of 12.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 624.13M | 47.88% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | 347.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jade Biosciences | 656.48M |
| Rigel Pharmaceuticals | 643.65M |
| ProKidney | 628.74M |
| Lexicon Pharmaceuticals | 627.81M |
| MeiraGTx Holdings | 599.66M |
| LB Pharmaceuticals | 599.59M |
| YD Bio | 583.65M |
| Prime Medicine | 578.91M |